Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Evotec AG (EVO) vs Kamada Ltd. (KMDA)

Evotec AG and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Evotec AG and Kamada Ltd. are of similar size ($539.9M and $509.4M). Evotec AG has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 22.9×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against 2.15%. Kamada Ltd. has the higher net margin (11.6% vs −26.2%) and the higher return on invested capital (8.47% vs 0.00%). Across the 19 metrics below, Kamada Ltd. leads on 14 and Evotec AG on 5.

Valuation

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
P/E n/m 22.95 20.14
P/S 0.64 2.63 2.25
P/B 0.72 1.87 1.90
Price to free cash flow n/m 19.18 16.54
EV/EBITDA n/m 10.33 12.29
EV/Sales 0.65 2.32 2.56
Earnings yield (40.90%) 4.36% (2.99%)
Free cash flow yield (36.14%) 5.21% 0.00%

Profitability

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 40.82% 53.94%
Operating margin (21.35%) 14.51% 0.00%
Net margin (26.20%) 11.60% 0.00%
Free cash flow margin 0.00% 13.72% 0.00%
Return on equity 0.00% 8.40% (0.40%)
Return on assets 0.00% 5.92% (3.32%)
Return on invested capital 0.00% 8.47% 0.00%

Growth

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 13.17% 10.01%
EPS growth (last fiscal year) 44.89% 40.00% —
Revenue growth, 5-year CAGR 9.28% 6.25% 6.74%
Net income growth, 5-year CAGR 0.00% 3.34% 0.00%

Health

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.02 0.05
Current ratio 2.33 4.06 2.31
Net debt to EBITDA (0.64) (1.59) 0.85

Dividend

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric EVO KMDA Drug Manufacturers Specialty & Generic median
Market cap 539.87m 509.40m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack